Skip to main content
. 2024 Apr 30;20(1):2342630. doi: 10.1080/21645515.2024.2342630

Figure 2.

Figure 2.

Participant disposition.

Ih group: study participants receiving DTPa‑HBV‑IPV/Hib vaccine; Va group: study participants receiving DTaP5‑HB‑IPV‑Hib vaccine

N, number of participants with available results; PPS: per protocol set, includes all study participants who received all study vaccinations and complied with all study-related interventions and conditions as defined in the study protocol.